In the News
Westport Pharmaceuticals is actively engaged in developing and commercializing highly effective pseudoephedrine-based products that have the added benefit of tamper resistance. Consumers get congestion relief, while society is protected from meth-related crime.
Below is a listing of our most recent news releases and stories.
Thursday, November 7th, 2013
Meth is a big problem in New Mexico, but a new cold drug on the market is meant to make that more difficult. It’s called Zephrex-D, and…
Click here to read full story and view video report »
Tuesday, November 5th, 2013
In the middle of the country’s methamphetamine epidemic, Highland Pharmaceuticals in Missouri has created a way to prevent pseudoephedrine from being ground into powder. The sinus medication is used as an ingredient in meth, but only if it could be turned into powder first. Jeff Glor reports.
Click here to read full story and view video report
Thursday, September 5th, 2013
ST. LOUIS, September 5, 2013 — The nation’s foremost decongestant, pseudoephedrine, a favorite of sinus-suffering consumers and meth-making criminals, is now available nationally in a product designed specifically for consumers and against criminals. Zephrex-D® cannot be used to make methamphetamine (meth) with the widespread and dangerous “one pot shake and bake” process, according to testing and statements from narcotics officers.
Click here to read full story
Tuesday, December 4th, 2012
St. Louis, MO – December 4, 2012 – Westport Pharmaceuticals, a St. Louis-based, specialty pharmaceutical company focused on OTC consumer healthcare products with abuse deterrent technology, announced today the arrival of Zephrex-D™, a tamper-resistant pseudoephedrine-based decongestant, now available in retail stores throughout the St. Louis region and the state of Missouri. Read More →
Friday, November 9th, 2012
Friday, November 2nd, 2012
Wednesday, October 24th, 2012